Free Trial

Braskem (NYSE:BAK) Announces Earnings Results, Misses Estimates By $0.01 EPS

Braskem logo with Oils/Energy background
Remove Ads

Braskem (NYSE:BAK - Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.39) EPS for the quarter, missing the consensus estimate of ($0.38) by ($0.01), Zacks reports. The firm had revenue of $3.28 billion for the quarter, compared to the consensus estimate of $3.52 billion. Braskem had a negative net margin of 9.88% and a negative return on equity of 439.59%.

Braskem Stock Performance

Shares of Braskem stock traded down $0.18 during trading on Monday, hitting $3.51. The company's stock had a trading volume of 1,046,990 shares, compared to its average volume of 866,070. Braskem has a 52 week low of $3.50 and a 52 week high of $10.98. The company has a market capitalization of $1.40 billion, a PE ratio of -0.99 and a beta of 2.03. The company has a fifty day simple moving average of $4.28 and a two-hundred day simple moving average of $5.41.

Analyst Upgrades and Downgrades

Separately, Scotiabank lowered shares of Braskem from a "sector outperform" rating to a "sector perform" rating in a report on Monday.

Read Our Latest Research Report on BAK

About Braskem

(Get Free Report)

Braskem SA, together with its subsidiaries, produces and sells thermoplastic resins. The company operates through three segments: Brazil, United States and Europe, and Mexico. The Brazil segment produces and sells olefins, including ethylene, polymer and chemical grade propylene, butadiene, and butene-1; benzene, toluene, and xylenes products; fuels, such as automotive gasoline, liquefied petroleum gas, ethyl tertiary-butyl ether, and methyl tertiary-butyl ether; intermediates, such as cumene; aliphatics, aromatics, and hydrogenated solvents; and specialties comprising isoprene, dicyclopentadiene, piperylene, nonene, tetramer, polyisobutylene, and hydrocarbon resins.

Featured Stories

Earnings History for Braskem (NYSE:BAK)

Should You Invest $1,000 in Braskem Right Now?

Before you consider Braskem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Braskem wasn't on the list.

While Braskem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Is There Still Money in AI? How to Invest in the Next Big Wave
AMD at Rock Bottom? Analysts Predict a MAJOR Rebound!
Massive Buybacks: 3 Stocks Insiders Are Buying Up

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads